Wird geladen...
Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
BACKGROUND: Modern guidelines recommend sodium-glucose cotransporter-2 (SGLT2) inhibitors as the preferred antihyperglycemic agents for patients with type 2 diabetes and chronic kidney disease. However, the mechanisms underlying the renal protective effect of SGLT2 inhibitors are not fully understoo...
Gespeichert in:
| Veröffentlicht in: | World J Diabetes |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754166/ https://ncbi.nlm.nih.gov/pubmed/33384767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v11.i12.596 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|